Down-regulation of urokinase secretion from a human lymphoma cell line RC-K8 by dexamethasone without inducing plasminogen activator inhibitors.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Thrombosis Research

• Publication date

  1992-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0049-3848(92)90162-4PMID 1631798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dexamethasone and Phorbol Ester, but not Cytokines, Increase the Production of Plasminogen Activator Inhibitor Type-2 in the PL-21 Human Promyelocytic Leukemia Cell Line

  1991cited by this paper
• A Plasminogen Activator Inhibitor-2 from a Promyelocytic Leukemia Cell Line, PL-21, Binds to the Carboxy-Terminal Chain of Plasminogen Activators

  1990cited by this paper
• Inhibition of endothelial secretion of tissue-type plasminogen activator and its rapid inhibitor by agents which increase intracellular cyclic AMP.

  1989cited by this paper
• Differentiation-linked expression of the plasminogen activator inhibitor type-2 gene in the human HL-60 promyelocytic cell line.

  1989cited by this paper
• Stimulated production of urokinase and plasminogen activator inhibitor-2 by the human promyelocytic leukemia cell line HL-60.

  1988cited by this paper
• Plasminogen activator inhibitor type-1 protein, mRNA and gene transcription are increased by phorbol esters in human rhabdomyosarcoma cells.

  1988cited by this paper
• Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2

  1988cited by this paper
• Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231.

  1987cited by this paper
• Dexamethasone coordinately inhibits plasminogen activator gene expression and enzyme activity in porcine kidney cells.

  1987cited by this paper
• Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells

  1987cited by this paper
• Purification and Characterization of Single-Chain Urokinase-Type Plasminogen Activator (Pro-Urokinase) from Human A431 Cells

  1986cited by this paper
• Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937.

  1986cited by this paper
• Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures.

  1986cited by this paper
• Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines

  1986cited by this paper
• Glucocorticoid inhibition of urokinase-like plasminogen activators in cultured human lymphoblasts.

  1985cited by this paper
• Establishment of a new human lymphoma line that secretes plasminogen activator.

  1985cited by this paper
• Hormonal control of plasminogen activator secretion in ZR-75-1 human breast cancer cells in culture.

  1984cited by this paper
• Dexamethasone induction of an inhibitor of plasminogen activator in HTC hepatoma cells.

  1984cited by this paper
• The effects of dexamethasone and tetradecanoyl phorbol acetate on plasminogen activator release by human acute myeloid leukemia cells.

  1983cited by this paper
• Spectrometric Determination of Urokinase in Urine after Gel Filtration, Using the Chromogenic Substrate S-2444

  1980cited by this paper
• Dexamethasone regulation of plasminogen activator in embryonic and tumor-derived human cells.

  1980cited by this paper
• Mechanism of dexamethasone inhibition of plasminogen activator in rat hepatoma cells.

  1978cited by this paper
• A study of proteases and protease-inhibitor complexes in biological fluids

  1978cited by this paper
• Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate.

  1977cited by this paper
• Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors

  1977cited by this paper
• Tumour promotor induces plasminogen activator

  1976cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Effect of a Congolese herbal medicine used in sickle cell anemia on the expression of plasminogen activators in human coronary aortic endothelial cells culture.

  2013cites this paper
• Amurubicinol-induced eotaxin-3 expression in human NCI-H69 small cell lung carcinoma cells.

  2006cites this paper
• Involvement of ERK1/2 and p38 MAP Kinase in Doxorubicin-Induced uPA Expression in Human RC-K8 Lymphoma and NCI-H69 Small Cell Lung Carcinoma Cells

  2004cites this paper
• Induction of urokinase‐type plasminogen activator by the anthracycline antibiotic in human RC‐K8 lymphoma and H69 lung‐carcinoma cells

  2001cites this paper
• Oxidative stress induces urokinase-type plasminogen activator in RC-K8 human malignant lymphoma cells and H69 human small cell lung carcinoma cells

  2000cites this paper
• Induction of urokinase-type plasminogen activator by lipopolysaccharide in PC-3 human prostatic cancer cells.

  2000cites this paper
• The effect of dexamethasone on tissue fibrinolytic system in male and female rats.

  1999cites this paper
• Transcriptional Regulation of Urokinase-type Plasminogen Activator Receptor by Cyclic AMP in PL-21 Human Myeloid Leukemia Cells: Comparison with the Regulation by Phorbol Myristate Acetate

  1998cites this paper
• Effect of dexamethasone on invasion of human squamous cell carcinoma cells into collagen gel.

  1996cites this paper
• Inhibitory Effect of a Synthetic Prostacyclin Analogue, Beraprost, on Urokinase-type Plasminogen Activator Expression in RC-K8 Human Lymphoma Cells

  1996cites this paper
• Modulation of Urokinase-type Plasminogen Activator Gene Expression by Inflammatory Cytokines in Human pre-B Lymphoma Cell Line RC-K8

  1995cites this paper
• Induction of urinary plasminogen activator by retinoic acid results in increased invasiveness of human prostate cancer cells PC‐3

  1995cites this paper
• Protein kinase activity-dependent inhibition of urokinase-type plasminogen activator gene transcription by cyclic AMP in human pre-B lymphoma cell line RC-K8.

  1995cites this paper
• Low levels of plasminogen activator inhibitor type 1 in patients with inflammatory bowel disease

  1994cites this paper